Fairmount Funds Management’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,393,329
| Closed | -$22.9M | – | 16 |
|
|
2024
Q1 | $22.9M | Hold |
1,393,329
| – | – | 2.49% | 12 |
|
|
2023
Q4 | $19.3M | Hold |
1,393,329
| – | – | 2.04% | 14 |
|
|
2023
Q3 | $19.2M | Sell |
1,393,329
-23,669
| -2% | -$326K | 2.31% | 15 |
|
|
2023
Q2 | $24.1M | Hold |
1,416,998
| – | – | 3.4% | 9 |
|
|
2023
Q1 | $22.8M | Hold |
1,416,998
| – | – | 3.92% | 11 |
|
|
2022
Q4 | $10.8M | Hold |
1,416,998
| – | – | 1.71% | 15 |
|
|
2022
Q3 | $12.5M | Hold |
1,416,998
| – | – | 2.19% | 15 |
|
|
2022
Q2 | $10.1M | Buy |
1,416,998
+132,008
| +10% | +$944K | 2.32% | 19 |
|
|
2022
Q1 | $13.7M | Buy |
1,284,990
+639,641
| +99% | +$6.84M | 3.25% | 12 |
|
|
2021
Q4 | $9.08M | Buy |
645,349
+146,309
| +29% | +$2.06M | 2.99% | 12 |
|
|
2021
Q3 | $8.78M | Buy |
+499,040
| New | +$8.78M | 3.19% | 13 |
|